NOTICE OF AVAILABILITY OF ADMINISTRATIVE SUPPLEMENTS FOR DISSEMINATING EVIDENCE - BASED INTERVENTION RESEARCH PRODUCTS RELEASE DATE: April 5, 2004 NOTICE: NOT-CA-04-011 National Cancer Institute (NCI) (http://cancer.gov/) The National Cancer Institute is requesting applications for administrative supplements for NCI-funded cancer control intervention research RO1, P01, P50, U01, and U19 grants. Applicants may apply for a supplement to a related R01, P01, P50, U01, or U19 intervention research award, as long as the following conditions are met: 1) The focus of the awarded grant is similar to the focus of the intervention dissemination supplement that is being proposed, 2) There are no funds in the related award related to the proposed dissemination effort. 3) There must be an active parent grant during the entire funding period of this supplement. 4) The Principal Investigator for the supplement must be the Principal Investigator of the parent grant. These supplements have been designed to provide 1-year funding to cancer control investigators whose intervention efficacy data have been analyzed and who are conducting peer-reviewed research (with an active NCI grant award) related to the intervention program proposed for dissemination. Intervention research across the cancer control continuum that may be eligible for these supplements, includes: tobacco use prevention and cessation; promotion of appropriate changes in diet and physical activity; reduction of sun exposure and ultraviolet (UV) radiation exposure; facilitation of informed decisions about genetic testing for cancer susceptibility; enhancement of screening for breast, cervix and colorectal cancers; quality of care; and improvements in coping skills and quality-of-life for cancer survivors and their families. Detailed instructions for applying for this supplement will be posted at http://www.dccps.cancer.gov/funding_apply.html#dd.on April 7, 2004. The receipt date for applications is June 30, 2004. The application should take the form of a request letter that contains sufficient detail to allow assessment of the scientific merit of the proposed dissemination plans and the appropriateness of the request for supplemental funding (see web site for more detailed application information). Budgets should not exceed $125,000 in direct costs for a time period not exceeding 12 months. All requests require an itemized budget and must be countersigned by the grantee institution’s business office. Requests for supplements under this program must comply with NIH policies for inclusion of women, minorities, and children in research involving human subjects. Request letters will be evaluated by NCI program staff (and appropriate consultants) who have expertise in the cancer control intervention area and/or in dissemination and diffusion research. Awards will be determined on the basis of scientific merit, program relevance, dissemination potential, and availability of funds. Special consideration will be given to applications that include plans to disseminate interventions tested in low income and ethnically diverse populations. The earliest anticipated award date for this program will be September 1, 2004. Inquiries related to this notice should be addressed to the NCI Program Director for the particular R01, P01, P50, U01, or U19 for which the supplement is being requested. Before submitting an applicant, each applicant (i.e., Principal Investigator) is encouraged to discuss the efficacy data (e.g., effect sizes, consistency with prior research, relevance to target populations) supporting their competing supplement request from the original project with their respective NCI research project Program Director. INQUIRIES Direct inquiries concerning the programmatic and review matters to: Jon F. Kerner, Ph.D. Deputy Director for Research Dissemination and Diffusion Division of Cancer Control and Population Sciences 6130 Executive Boulevard, EPN Room 6144 Bethesda, MD 20892-0001 Rockville, MD 20852 (for courier/express service) Telephone: 301-594-7294 E-mail: email@example.com Direct inquiries regarding fiscal matters should be made to: Ms. Crystal Wolfrey Grants Administration Branch 6120 Executive Boulevard, EPS Room 243 Bethesda, MD 20892-7150 Rockville, MD 20852 (for courier/express service) Telephone: 301-496-8634 E-mail: firstname.lastname@example.org SUBMISSION OF APPLICATION Submit a signed, typewritten original of the request letter and five signed, single-sided photocopies, in one package to: Cynthia Vinson, M.P.A. Dissemination and Diffusion Coordinator Division of Cancer Control and Population Sciences National Cancer Institute 6130 Executive Blvd., EPN Room 6146 Bethesda, MD 20892-0001 Rockville, MD 20852 (for express/courier service) DO NOT SUBMIT THE APPLICATIONS TO THE CENTER FOR SCIENTIFIC REVIEW (CSR).
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Department of Health
and Human Services
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892